TFS Capital’s Select Medical SEM Stock Holding History

TFS Capital’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-30,594	Closed	-$220K	–	755
2017 Q1	$220K	Buy	+30,594	New	+$222K	0.07%	459
2016 Q4	–	Sell	-19,022	Closed	-$138K	–	875
2016 Q3	$138K	Sell	19,022 -10,128	-35%	-$64.4K	0.03%	611
2016 Q2	$171K	Buy	+29,150	New	+$193K	0.03%	762
2016 Q1	–	Sell	-302,632	Closed	-$1.94M	–	1086
2015 Q4	$1.94M	Buy	+302,632	New	+$1.89M	0.21%	172
2015 Q3	–	Sell	-133,303	Closed	-$1.16M	–	1025
2015 Q2	$1.16M	Buy	+133,303	New	+$1.12M	0.11%	297
2015 Q1	–	Sell	-278,528	Closed	-$2.16M	–	1113
2014 Q4	$2.16M	Sell	278,528 -351,298	-56%	-$2.56M	0.21%	128
2014 Q3	$4.08M	Buy	629,826 +319,705	+103%	+$2.47M	0.35%	50
2014 Q2	$2.61M	Sell	310,121 -90,465	-23%	-$701K	0.21%	129
2014 Q1	$2.69M	Sell	400,586 -415,215	-51%	-$2.52M	0.18%	152
2013 Q4	$5.1M	Buy	815,801 +535,094	+191%	+$2.61M	0.24%	102
2013 Q3	$1.22M	Sell	280,707 -621,526	-69%	-$2.84M	0.06%	509
2013 Q2	$3.99M	Buy	+902,233	New	+$4M	0.17%	142

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TFS Capital's SEM Position: Q2 2017 in Review

TFS Capital sold out of Select Medical (SEM) in Q2 2017, closing a stake of 30,594 shares — an estimated $220K sold.

TFS Capital first reported a position in SEM in Q2 2013 and held it in 12 quarters. The position peaked at $5.1M in Q4 2013. 155 funds tracked by Wall St. Rank hold SEM as of Q2 2017.

TFS Capital reported no remaining Select Medical position as of Q2 2017 after selling out during the quarter.
TFS Capital sold 30,594 Select Medical shares in Q2 2017, an estimated $220K.
TFS Capital first reported a position in Select Medical in Q2 2013 and held it in 12 quarters.
TFS Capital's Select Medical position peaked at $5.1M in Q4 2013.
155 funds tracked by Wall St. Rank held Select Medical as of Q2 2017.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.